By Puyaan Singh (Reuters) -KalVista Pharmaceuticals’ said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a type of hereditary swelling disorder due to heavy workload and limited resources. The FDA indicated that it now expects to deliver a decision within four weeks, KalVista said. The original target action date for the decision on the medication, ...
WASHINGTON (Reuters) -Nippon Steel’s $14.9 billion bid for U.S. Steel poses a national security risk, but those concerns can be mitigated if the companies fulfill certain conditions laid out by the Trump administration, U.S. President Donald Trump said in a executive order on Friday. "I additionally find that the threatened impairment to the national security of the United States arising as a re ...
(Reuters) -Trump Media and Technology Group said on Friday that the U.S. Securities and Exchange Commission has declared effective the registration for its bitcoin treasury deal. The company said it raised about $2.3 billion through a mix of debt and equity agreements with participation from around 50 investors. It said in May that the bitcoin will be held on Trump Media’s balance sheet alongsi ...
By Ahmed Aboulenein WASHINGTON (Reuters) -U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday he promised to allow U.S. Senator Bill Cassidy to pick a candidate for a key panel of vaccine advisers. Kennedy, who has a long history of questioning the safety of vaccines contrary to scientific evidence, named eight members on Wednesday to serve on the U.S. Centers for Disea ...